The GLP-1 Effect: How Weight Loss Drugs Are Reshaping the Food Industry

In this episode of Oh For Food’s Sake, we explore one of the hottest and most impactful topics currently swirling around the food industry: GLP-1 drugs (think Ozempic, Wegovy, and Mounjaro). With these "wonder drugs" becoming more and more mainstream—not just as treatments for type 2 diabetes but as formidable tools for weight loss—they’re shaking up not only health narratives but also how, what, and why people eat. We unpack how these drugs dull appetite, reduce “food noise,” and could seriously shift the demand for everything from indulgent snacks to the next big protein or hydration trend. We tackle the challenge head-on: what does this seismic shift mean for product development, menu offering, and even the emotional ties we all have to food? Beyond the technical talk, we explore the emotional impact, societal divide, and unintended consequences for consumers and businesses. If you work in or with food—and haven’t clocked the GLP-1 tidal wave yet—this is your wake-up (and it’s anything but boring).